Together, our preclinical and patient data demonstrate that activation of the AR-FUT4 axis contributes to the disparately worse clinical outcomes observed in male patients by disrupting cellular adhesion and driving tumor cell migration and invasion. This evidence concerns the gene AR and neoplasm.